Financials
Financial year 2025
Gross margin
€ 0
Profit
Growing€ 2.2 million
▲ 125% vs 2024
Debts
Low€ 7 million
▲ 428% vs 2024
Palex Duomed Holding from Mechelen, company number BE1007767345, closed financial year 2025 with a result of € 2.2 million after tax. For that financial year Palex Duomed Holding recorded a gross margin of € 0 and equity of € 293.9 million. Compared with financial year 2024, the result moved from € -9 million to € 2.2 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
What happened at Palex Duomed Holding?
What happened at Palex Duomed Holding in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 2.2 million. Source: NBB ↗
- Levico BV became a director. NBB
- FH Impact Management BV stepped down as director. NBB
- D&Q Finexperts BV stepped down as director. NBB
- FH Impact Management BV became a director. NBB
- D&Q Finexperts BV became a director. NBB
- Carbosalutis S.L.U. became a director. NBB
- New establishment in Mechelen. KBO
In short
From € 9 million loss in 2024 to € 2.2 million profit in 2025.
Paid € 100,416 in corporate taxes since 2024.
Best year ever: 2025, with € 2.2 million profit.
Pays suppliers within 47 days on average.
A new publication or filing at Palex Duomed Holding? We notify you, reason included.
Follow Palex Duomed HoldingNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Palex Duomed Holding are Levico BV and Carbosalutis S.L.U.. It owns 100% of Hermes Acquireco and 100% of Duomed Holding Benelux itself.
Directors
According to the 2025 annual accounts
Managing director · represented by Geert Kuys
Also active at: ORTHOSPINE, DUOMED BELGIUM, Duomed Holding Benelux +1 more
since 2025
Carbosalutis S.L.U.
Director · represented by Francesc Xavier Carbonell Castellon
since 2024
Managing director · represented by Frédéric Hoffmann
Also active at: ORTHOSPINE, DUOMED BELGIUM, ARCHER RESEARCH +2 more
since 2024 · until 2025
Director · represented by Kristof Marivoet
Also active at: ORTHOSPINE, Duomed Holding Benelux
since 2024 · until 2025
Establishments
Establishment units
Physical locations of this company
Vaartdijk 90
2800 Mechelen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 18 companies are registered at this address.
ORTHOSPINE same network
€ 46,117 revenue · 2025
AXI
€ 26.7 million revenue · 2025
DUOMED BELGIUM same network
€ 113.3 million revenue · 2025
AMISTA
€ 2.5 million gross margin · 2025
Duomed Holding Benelux same network
+13 more
Details
- Company number
- 1007.767.345
- VAT number
- BE 1007.767.345
- Registered office
- Vaartdijk 90, 2800 Mechelen
- Names & denominations
- Palex Duomed Holding
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 March 2024
- Peppol
- Active · Active since 19 Jan 2026
- Activities · NACE
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van holdings
Holdings